In-vitro binding analysis of anti-human vascular endothelial growth factor antibodies bevacizumab and aflibercept with canine, feline, and equine vascular endothelial growth factor-Reference-Cited by-同舟云学术

In-vitro binding analysis of anti-human vascular endothelial growth factor antibodies bevacizumab and aflibercept with canine, feline, and equine vascular endothelial growth factor

Published:2019-06 Issue: Volume:124 Page:233-238
ISSN:0034-5288
Container-title:Research in Veterinary Science
language:en
Short-container-title:Research in Veterinary Science

Author:

Muellerleile Lisa-Marie^ORCID,Buxbaum Bernhard,Nell Barbara,Fux Daniela A.

Publisher

Elsevier BV

Subject

General Veterinary

Reference44 articles.

1. Gapped BLAST and PSI-BLAST : a new generation of protein database search programs;Altschul;Nucleic Acids Res.,1997

2. Predicting the kinetics of peptide-antibody interactions using a multivariate experimental design of sequence and chemical space;Andersson;J. Mol. Recognit.,2001

3. Primary intravitreal bevacizumab (Avastin) for diabetic macular edema. Results from the pan-American collaborative retina study group at 6-month follow-up;Arevalo;Ophthalmology,2007

4. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration;Avery;Ophthalmology,2006

5. Expression of vascular endothelial growth factor receptor-1 and -2 in normal and diseased canine eyes;Binder;Vet. Ophthalmol.,2012

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. VEGF-A165a and angiopoietin-2 differently affect the barrier formed by retinal endothelial cells;Experimental Eye Research;2024-10

2. Adjunctive bevacizumab therapy in an equine corneal stromal invasive squamous cell carcinoma with a 53-months follow-up;Tierärztliche Praxis Ausgabe G: Großtiere / Nutztiere;2024-04

3. Bevacizumab Efficiently Inhibits VEGF-Associated Cellular Processes in Equine Umbilical Vein Endothelial Cells: An In Vitro Characterization;Veterinary Sciences;2023-10-26

4. A Scoping Review on Tyrosine Kinase Inhibitors in Cats: Current Evidence and Future Directions;Animals;2023-09-29

5. Successful treatment of equine corneal neovascularisation by subconjunctival aflibercept;Veterinary Record Case Reports;2023-09-25